Pharmacy benefit managers CVS Caremark, OptumRx and Express Scripts inflated costs for specialty generic drugs to treat diseases such as cancer and HIV to the tune of $7.3 billion over six years ...

Plan sponsors’ spending on specialty generics rose by 21% yearly for commercial claims between 2017-2021, with patients paying $297 million. Get Wall Street's Hottest Chart Every Morning The ...

(Bloomberg) -- Units of CVS Health Corp ... is lowering the cost of specialty medications and helped patients save $1.3 billion in 2024, with a typical out-of-pocket payment of $5.

CVS), Cigna (CI) and UnitedHealth Group (UNH) significantly marked up prices for many specialty generic drugs over a six-year period. The interim staff report, which focused on middlemen in the ...

CVS says their clients’ specialty drug spend increased by 3.7 ... patients save $1.3 billion and the median out-of-pocket payment for these patients was $5." Express Scripts called the report ...